Former President and Chief Scientific Officer · Forte Biosciences, Inc. (FBRX)

Hubert Chen

A named executive officer of Forte Biosciences in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$230,337

Salary $50,337Stock awards $0

FY2023: $573,600

3rd of 3 named executive officers at Forte Biosciences by FY2024 total.

3 named officers on file for Forte Biosciences, FY2024

Hubert Chen’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 1 equity grant, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Forte Biosciences’s whole pay program stands against its peers

  • Forte Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on FBRX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 30, 2025 (DEF 14A).

Free

Get Hubert Chen’s full pay file as a PDF — free

More than this page: up to 10 years of Hubert’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Hubert Chen compensation by year

Forte Biosciences Summary Compensation Table · all 3 fiscal years held
In US dollars, as Forte Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024
Salary$255,682$450,000$50,337
Bonus$102,575$0$0
Stock awards$0$123,600$0
Option awards$211,600$0$0
Non-equity incentive——$180,000
Pension and deferred compensation$0$0$0
All other$0$0$0
Total$569,857$573,600$230,337

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Forte Biosciences, Inc. DEF 14A filed April 30, 2025, accession 0001193125-25-107130, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Forte Biosciences, Inc. filed document, accession 0001193125-25-107130. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.

$570K
$574K
$230K
FY22
FY23
FY24
SalaryBonusNon-equity incentiveStock awardsOption awards

Equity holdings

unvested awards at FY2023 year-end
TypeUnvested unitsValue at year-endExercise price
RSU97,500$100,425—
Option156,250—$1.30

Per the Outstanding Equity Awards at Fiscal Year-End table in Forte Biosciences, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.

Forte Biosciences’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
Paul WagnerChairman, President and Chief Executive Officer$1,674,458
Antony RileyChief Financial Officer$856,875
Hubert Chen · this pageFormer President and Chief Scientific Officer$230,337

The full Forte Biosciences compensation record

free company brief

This page is one person within Forte Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Forte Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Hubert Chen's compensation dossier · One-time report. No refunds.